img

Global Influenza NA Inhibitor Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Influenza NA Inhibitor Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Neuraminidase enzymes are glycoside hydrolase enzymes that cleave (cut) the glycosidic linkages of neuraminic acids. The viral neuraminidases are frequently used as antigenic determinants found on the surface of the influenza virus.
Influenza NA Inhibitor report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Influenza NA Inhibitor market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Influenza A Treatment and Influenza B Treatment are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Influenza NA Inhibitor industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Influenza NA Inhibitor key manufacturers include Green Cross, Roche, GlaxoSmithKline, Henan DaKen Chemical, ATK Chemical, Chemwill Asia Co.,Ltd., Shionogi Co., NeoPharm and Moksha8 Pharma, etc. Green Cross, Roche, GlaxoSmithKline are top 3 players and held % sales share in total in 2022.
Influenza NA Inhibitor can be divided into Zanamivir, Oseltamivir and Peramivir,, etc. Zanamivir is the mainstream product in the market, accounting for % sales share globally in 2022.
Influenza NA Inhibitor is widely used in various fields, such as Influenza A Treatment and Influenza B Treatment, etc. Influenza A Treatment provides greatest supports to the Influenza NA Inhibitor industry development. In 2022, global % sales of Influenza NA Inhibitor went into Influenza A Treatment filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Influenza NA Inhibitor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Green Cross
Roche
GlaxoSmithKline
Henan DaKen Chemical
ATK Chemical
Chemwill Asia Co.,Ltd.
Shionogi Co.
NeoPharm
Moksha8 Pharma
Segment by Type
Zanamivir
Oseltamivir
Peramivir

Segment by Application


Influenza A Treatment
Influenza B Treatment

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Influenza NA Inhibitor market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Influenza NA Inhibitor, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Influenza NA Inhibitor industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Influenza NA Inhibitor in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Influenza NA Inhibitor introduction, etc. Influenza NA Inhibitor Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Influenza NA Inhibitor market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Influenza NA Inhibitor Market Overview
1.1 Influenza NA Inhibitor Product Overview
1.2 Influenza NA Inhibitor Market Segment by Type
1.2.1 Zanamivir
1.2.2 Oseltamivir
1.2.3 Peramivir
1.3 Global Influenza NA Inhibitor Market Size by Type
1.3.1 Global Influenza NA Inhibitor Market Size Overview by Type (2018-2034)
1.3.2 Global Influenza NA Inhibitor Historic Market Size Review by Type (2018-2024)
1.3.3 Global Influenza NA Inhibitor Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Influenza NA Inhibitor Sales Breakdown by Type (2018-2024)
1.4.2 Europe Influenza NA Inhibitor Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Influenza NA Inhibitor Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Influenza NA Inhibitor Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Influenza NA Inhibitor Sales Breakdown by Type (2018-2024)
2 Global Influenza NA Inhibitor Market Competition by Company
2.1 Global Top Players by Influenza NA Inhibitor Sales (2018-2024)
2.2 Global Top Players by Influenza NA Inhibitor Revenue (2018-2024)
2.3 Global Top Players by Influenza NA Inhibitor Price (2018-2024)
2.4 Global Top Manufacturers Influenza NA Inhibitor Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza NA Inhibitor Market Competitive Situation and Trends
2.5.1 Influenza NA Inhibitor Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza NA Inhibitor Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza NA Inhibitor as of 2022)
2.7 Date of Key Manufacturers Enter into Influenza NA Inhibitor Market
2.8 Key Manufacturers Influenza NA Inhibitor Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Influenza NA Inhibitor Status and Outlook by Region
3.1 Global Influenza NA Inhibitor Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Influenza NA Inhibitor Historic Market Size by Region
3.2.1 Global Influenza NA Inhibitor Sales in Volume by Region (2018-2024)
3.2.2 Global Influenza NA Inhibitor Sales in Value by Region (2018-2024)
3.2.3 Global Influenza NA Inhibitor Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Influenza NA Inhibitor Forecasted Market Size by Region
3.3.1 Global Influenza NA Inhibitor Sales in Volume by Region (2024-2034)
3.3.2 Global Influenza NA Inhibitor Sales in Value by Region (2024-2034)
3.3.3 Global Influenza NA Inhibitor Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Influenza NA Inhibitor by Application
4.1 Influenza NA Inhibitor Market Segment by Application
4.1.1 Influenza A Treatment
4.1.2 Influenza B Treatment
4.2 Global Influenza NA Inhibitor Market Size by Application
4.2.1 Global Influenza NA Inhibitor Market Size Overview by Application (2018-2034)
4.2.2 Global Influenza NA Inhibitor Historic Market Size Review by Application (2018-2024)
4.2.3 Global Influenza NA Inhibitor Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Influenza NA Inhibitor Sales Breakdown by Application (2018-2024)
4.3.2 Europe Influenza NA Inhibitor Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Influenza NA Inhibitor Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Influenza NA Inhibitor Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Influenza NA Inhibitor Sales Breakdown by Application (2018-2024)
5 North America Influenza NA Inhibitor by Country
5.1 North America Influenza NA Inhibitor Historic Market Size by Country
5.1.1 North America Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Influenza NA Inhibitor Sales in Volume by Country (2018-2024)
5.1.3 North America Influenza NA Inhibitor Sales in Value by Country (2018-2024)
5.2 North America Influenza NA Inhibitor Forecasted Market Size by Country
5.2.1 North America Influenza NA Inhibitor Sales in Volume by Country (2024-2034)
5.2.2 North America Influenza NA Inhibitor Sales in Value by Country (2024-2034)
6 Europe Influenza NA Inhibitor by Country
6.1 Europe Influenza NA Inhibitor Historic Market Size by Country
6.1.1 Europe Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Influenza NA Inhibitor Sales in Volume by Country (2018-2024)
6.1.3 Europe Influenza NA Inhibitor Sales in Value by Country (2018-2024)
6.2 Europe Influenza NA Inhibitor Forecasted Market Size by Country
6.2.1 Europe Influenza NA Inhibitor Sales in Volume by Country (2024-2034)
6.2.2 Europe Influenza NA Inhibitor Sales in Value by Country (2024-2034)
7 Asia-Pacific Influenza NA Inhibitor by Region
7.1 Asia-Pacific Influenza NA Inhibitor Historic Market Size by Region
7.1.1 Asia-Pacific Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Influenza NA Inhibitor Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Influenza NA Inhibitor Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Influenza NA Inhibitor Forecasted Market Size by Region
7.2.1 Asia-Pacific Influenza NA Inhibitor Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Influenza NA Inhibitor Sales in Value by Region (2024-2034)
8 Latin America Influenza NA Inhibitor by Country
8.1 Latin America Influenza NA Inhibitor Historic Market Size by Country
8.1.1 Latin America Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Influenza NA Inhibitor Sales in Volume by Country (2018-2024)
8.1.3 Latin America Influenza NA Inhibitor Sales in Value by Country (2018-2024)
8.2 Latin America Influenza NA Inhibitor Forecasted Market Size by Country
8.2.1 Latin America Influenza NA Inhibitor Sales in Volume by Country (2024-2034)
8.2.2 Latin America Influenza NA Inhibitor Sales in Value by Country (2024-2034)
9 Middle East and Africa Influenza NA Inhibitor by Country
9.1 Middle East and Africa Influenza NA Inhibitor Historic Market Size by Country
9.1.1 Middle East and Africa Influenza NA Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Influenza NA Inhibitor Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Influenza NA Inhibitor Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Influenza NA Inhibitor Forecasted Market Size by Country
9.2.1 Middle East and Africa Influenza NA Inhibitor Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Influenza NA Inhibitor Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Green Cross
10.1.1 Green Cross Company Information
10.1.2 Green Cross Introduction and Business Overview
10.1.3 Green Cross Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Green Cross Influenza NA Inhibitor Products Offered
10.1.5 Green Cross Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Roche Influenza NA Inhibitor Products Offered
10.2.5 Roche Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GlaxoSmithKline Influenza NA Inhibitor Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Henan DaKen Chemical
10.4.1 Henan DaKen Chemical Company Information
10.4.2 Henan DaKen Chemical Introduction and Business Overview
10.4.3 Henan DaKen Chemical Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Henan DaKen Chemical Influenza NA Inhibitor Products Offered
10.4.5 Henan DaKen Chemical Recent Development
10.5 ATK Chemical
10.5.1 ATK Chemical Company Information
10.5.2 ATK Chemical Introduction and Business Overview
10.5.3 ATK Chemical Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2024)
10.5.4 ATK Chemical Influenza NA Inhibitor Products Offered
10.5.5 ATK Chemical Recent Development
10.6 Chemwill Asia Co.,Ltd.
10.6.1 Chemwill Asia Co.,Ltd. Company Information
10.6.2 Chemwill Asia Co.,Ltd. Introduction and Business Overview
10.6.3 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Products Offered
10.6.5 Chemwill Asia Co.,Ltd. Recent Development
10.7 Shionogi Co.
10.7.1 Shionogi Co. Company Information
10.7.2 Shionogi Co. Introduction and Business Overview
10.7.3 Shionogi Co. Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Shionogi Co. Influenza NA Inhibitor Products Offered
10.7.5 Shionogi Co. Recent Development
10.8 NeoPharm
10.8.1 NeoPharm Company Information
10.8.2 NeoPharm Introduction and Business Overview
10.8.3 NeoPharm Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2024)
10.8.4 NeoPharm Influenza NA Inhibitor Products Offered
10.8.5 NeoPharm Recent Development
10.9 Moksha8 Pharma
10.9.1 Moksha8 Pharma Company Information
10.9.2 Moksha8 Pharma Introduction and Business Overview
10.9.3 Moksha8 Pharma Influenza NA Inhibitor Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Moksha8 Pharma Influenza NA Inhibitor Products Offered
10.9.5 Moksha8 Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza NA Inhibitor Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza NA Inhibitor Industrial Chain Analysis
11.4 Influenza NA Inhibitor Market Dynamics
11.4.1 Influenza NA Inhibitor Industry Trends
11.4.2 Influenza NA Inhibitor Market Drivers
11.4.3 Influenza NA Inhibitor Market Challenges
11.4.4 Influenza NA Inhibitor Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Influenza NA Inhibitor Distributors
12.3 Influenza NA Inhibitor Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Zanamivir
Table 2. Major Company of Oseltamivir
Table 3. Major Company of Peramivir
Table 4. Global Influenza NA Inhibitor Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Influenza NA Inhibitor Sales by Type (2018-2024) & (Kilotons)
Table 6. Global Influenza NA Inhibitor Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Influenza NA Inhibitor Sales by Type (2018-2024) & (US& Million)
Table 8. Global Influenza NA Inhibitor Market Share in Value by Type (2018-2024)
Table 9. Global Influenza NA Inhibitor Price by Type (2018-2024) & (US$/Kg)
Table 10. Global Influenza NA Inhibitor Sales by Type (2024-2034) & (Kilotons)
Table 11. Global Influenza NA Inhibitor Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Influenza NA Inhibitor Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Influenza NA Inhibitor Sales Market Share in Value by Type (2024-2034)
Table 14. Global Influenza NA Inhibitor Price by Type (2024-2034) & (US$/Kg)
Table 15. North America Influenza NA Inhibitor Sales by Type (2018-2024) & (Kilotons)
Table 16. North America Influenza NA Inhibitor Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Influenza NA Inhibitor Sales (Kilotons) by Type (2018-2024)
Table 18. Europe Influenza NA Inhibitor Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Influenza NA Inhibitor Sales (Kilotons) by Type (2018-2024)
Table 20. Asia-Pacific Influenza NA Inhibitor Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Influenza NA Inhibitor Sales (Kilotons) by Type (2018-2024)
Table 22. Latin America Influenza NA Inhibitor Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Influenza NA Inhibitor Sales (Kilotons) by Type (2018-2024)
Table 24. Middle East and Africa Influenza NA Inhibitor Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Influenza NA Inhibitor Sales by Company (2018-2024) & (Kilotons)
Table 26. Global Influenza NA Inhibitor Sales Share by Company (2018-2024)
Table 27. Global Influenza NA Inhibitor Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Influenza NA Inhibitor Revenue Share by Company (2018-2024)
Table 29. Global Market Influenza NA Inhibitor Price by Company (2018-2024) & (US$/Kg)
Table 30. Global Influenza NA Inhibitor Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Influenza NA Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza NA Inhibitor as of 2022)
Table 33. Date of Key Manufacturers Enter into Influenza NA Inhibitor Market
Table 34. Key Manufacturers Influenza NA Inhibitor Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Influenza NA Inhibitor Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Influenza NA Inhibitor Sales by Region (2018-2024) & (Kilotons)
Table 38. Global Influenza NA Inhibitor Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Influenza NA Inhibitor Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Influenza NA Inhibitor Sales Market Share in Value by Region (2018-2024)
Table 41. Global Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 42. Global Influenza NA Inhibitor Sales by Region (2024-2034) & (Kilotons)
Table 43. Global Influenza NA Inhibitor Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Influenza NA Inhibitor Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Influenza NA Inhibitor Sales Market Share in Value by Region (2024-2034)
Table 46. Global Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2034)
Table 47. Global Influenza NA Inhibitor Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Influenza NA Inhibitor Sales by Application (2018-2024) & (Kilotons)
Table 49. Global Influenza NA Inhibitor Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Influenza NA Inhibitor Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Influenza NA Inhibitor Sales Market Share in Value by Application (2018-2024)
Table 52. Global Influenza NA Inhibitor Price by Application (2018-2024) & (US$/Kg)
Table 53. Global Influenza NA Inhibitor Sales by Application (2024-2034) & (Kilotons)
Table 54. Global Influenza NA Inhibitor Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Influenza NA Inhibitor Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Influenza NA Inhibitor Sales Market Share in Value by Application (2024-2034)
Table 57. Global Influenza NA Inhibitor Price by Application (2024-2034) & (US$/Kg)
Table 58. North America Influenza NA Inhibitor Sales by Application (2018-2024) (Kilotons)
Table 59. North America Influenza NA Inhibitor Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Influenza NA Inhibitor Sales by Application (2018-2024) (Kilotons)
Table 61. Europe Influenza NA Inhibitor Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Influenza NA Inhibitor Sales by Application (2018-2024) (Kilotons)
Table 63. Asia-Pacific Influenza NA Inhibitor Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Influenza NA Inhibitor Sales by Application (2018-2024) (Kilotons)
Table 65. Latin America Influenza NA Inhibitor Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Influenza NA Inhibitor Sales by Application (2018-2024) (Kilotons)
Table 67. Middle East and Africa Influenza NA Inhibitor Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Influenza NA Inhibitor Sales by Country (2018-2024) & (Kilotons)
Table 69. North America Influenza NA Inhibitor Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Influenza NA Inhibitor Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Influenza NA Inhibitor Sales Market Share in Value by Country (2018-2024)
Table 72. North America Influenza NA Inhibitor Sales by Country (2024-2034) & (Kilotons)
Table 73. North America Influenza NA Inhibitor Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Influenza NA Inhibitor Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Influenza NA Inhibitor Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Influenza NA Inhibitor Sales by Country (2018-2024) & (Kilotons)
Table 77. Europe Influenza NA Inhibitor Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Influenza NA Inhibitor Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Influenza NA Inhibitor Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Influenza NA Inhibitor Sales by Country (2024-2034) & (Kilotons)
Table 81. Europe Influenza NA Inhibitor Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Influenza NA Inhibitor Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Influenza NA Inhibitor Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Influenza NA Inhibitor Sales by Region (2018-2024) & (Kilotons)
Table 85. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Influenza NA Inhibitor Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Influenza NA Inhibitor Sales by Region (2024-2034) & (Kilotons)
Table 89. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Influenza NA Inhibitor Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Influenza NA Inhibitor Sales by Country (2018-2024) & (Kilotons)
Table 93. Latin America Influenza NA Inhibitor Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Influenza NA Inhibitor Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Influenza NA Inhibitor Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Influenza NA Inhibitor Sales by Country (2024-2034) & (Kilotons)
Table 97. Latin America Influenza NA Inhibitor Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Influenza NA Inhibitor Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Influenza NA Inhibitor Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Influenza NA Inhibitor Sales by Country (2018-2024) & (Kilotons)
Table 101. Middle East and Africa Influenza NA Inhibitor Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Influenza NA Inhibitor Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Influenza NA Inhibitor Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Influenza NA Inhibitor Sales by Country (2024-2034) & (Kilotons)
Table 105. Middle East and Africa Influenza NA Inhibitor Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Influenza NA Inhibitor Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Influenza NA Inhibitor Sales Market Share in Value by Country (2024-2034)
Table 108. Green Cross Company Information
Table 109. Green Cross Introduction and Business Overview
Table 110. Green Cross Influenza NA Inhibitor Sales (Kilotons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 111. Green Cross Influenza NA Inhibitor Product
Table 112. Green Cross Recent Development
Table 113. Roche Company Information
Table 114. Roche Introduction and Business Overview
Table 115. Roche Influenza NA Inhibitor Sales (Kilotons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 116. Roche Influenza NA Inhibitor Product
Table 117. Roche Recent Development
Table 118. GlaxoSmithKline Company Information
Table 119. GlaxoSmithKline Introduction and Business Overview
Table 120. GlaxoSmithKline Influenza NA Inhibitor Sales (Kilotons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 121. GlaxoSmithKline Influenza NA Inhibitor Product
Table 122. GlaxoSmithKline Recent Development
Table 123. Henan DaKen Chemical Company Information
Table 124. Henan DaKen Chemical Introduction and Business Overview
Table 125. Henan DaKen Chemical Influenza NA Inhibitor Sales (Kilotons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 126. Henan DaKen Chemical Influenza NA Inhibitor Product
Table 127. Henan DaKen Chemical Recent Development
Table 128. ATK Chemical Company Information
Table 129. ATK Chemical Introduction and Business Overview
Table 130. ATK Chemical Influenza NA Inhibitor Sales (Kilotons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 131. ATK Chemical Influenza NA Inhibitor Product
Table 132. ATK Chemical Recent Development
Table 133. Chemwill Asia Co.,Ltd. Company Information
Table 134. Chemwill Asia Co.,Ltd. Introduction and Business Overview
Table 135. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales (Kilotons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 136. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product
Table 137. Chemwill Asia Co.,Ltd. Recent Development
Table 138. Shionogi Co. Company Information
Table 139. Shionogi Co. Introduction and Business Overview
Table 140. Shionogi Co. Influenza NA Inhibitor Sales (Kilotons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 141. Shionogi Co. Influenza NA Inhibitor Product
Table 142. Shionogi Co. Recent Development
Table 143. NeoPharm Company Information
Table 144. NeoPharm Introduction and Business Overview
Table 145. NeoPharm Influenza NA Inhibitor Sales (Kilotons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 146. NeoPharm Influenza NA Inhibitor Product
Table 147. NeoPharm Recent Development
Table 148. Moksha8 Pharma Company Information
Table 149. Moksha8 Pharma Introduction and Business Overview
Table 150. Moksha8 Pharma Influenza NA Inhibitor Sales (Kilotons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2018-2024)
Table 151. Moksha8 Pharma Influenza NA Inhibitor Product
Table 152. Moksha8 Pharma Recent Development
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Influenza NA Inhibitor Market Trends
Table 156. Influenza NA Inhibitor Market Drivers
Table 157. Influenza NA Inhibitor Market Challenges
Table 158. Influenza NA Inhibitor Market Restraints
Table 159. Influenza NA Inhibitor Distributors List
Table 160. Influenza NA Inhibitor Downstream Customers
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza NA Inhibitor Product Picture
Figure 2. Global Influenza NA Inhibitor Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Influenza NA Inhibitor Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Influenza NA Inhibitor Sales Status and Outlook (2018-2034) & (Kilotons)
Figure 5. Product Picture of Zanamivir
Figure 6. Global Zanamivir Sales YoY Growth (2018-2034) & (Kilotons)
Figure 7. Product Picture of Oseltamivir
Figure 8. Global Oseltamivir Sales YoY Growth (2018-2034) & (Kilotons)
Figure 9. Product Picture of Peramivir
Figure 10. Global Peramivir Sales YoY Growth (2018-2034) & (Kilotons)
Figure 11. Global Influenza NA Inhibitor Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Influenza NA Inhibitor Sales Market Share by Type in 2022 & 2034
Figure 13. North America Influenza NA Inhibitor Sales Market Share in Volume by Type in 2022
Figure 14. North America Influenza NA Inhibitor Sales Market Share in Value by Type in 2022
Figure 15. Europe Influenza NA Inhibitor Sales Market Share in Volume by Type in 2022
Figure 16. Europe Influenza NA Inhibitor Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Value by Type in 2022
Figure 19. Latin America Influenza NA Inhibitor Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Influenza NA Inhibitor Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Influenza NA Inhibitor Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Influenza NA Inhibitor Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza NA Inhibitor Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza NA Inhibitor Revenue in 2022
Figure 25. Influenza NA Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Influenza A Treatment
Figure 27. Global Influenza A Treatment Sales YoY Growth (2018-2034) & (Kilotons)
Figure 28. Product Picture of Influenza B Treatment
Figure 29. Global Influenza B Treatment Sales YoY Growth (2018-2034) & (Kilotons)
Figure 30. Global Influenza NA Inhibitor Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Influenza NA Inhibitor Sales Market Share by Application in 2022 & 2034
Figure 32. North America Influenza NA Inhibitor Sales Market Share in Volume by Application in 2022
Figure 33. North America Influenza NA Inhibitor Sales Market Share in Value by Application in 2022
Figure 34. Europe Influenza NA Inhibitor Sales Market Share in Volume by Application in 2022
Figure 35. Europe Influenza NA Inhibitor Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Influenza NA Inhibitor Sales Market Share in Value by Application in 2022
Figure 38. Latin America Influenza NA Inhibitor Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Influenza NA Inhibitor Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Influenza NA Inhibitor Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Influenza NA Inhibitor Manufacturing Cost Structure
Figure 43. Influenza NA Inhibitor Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries